脓毒症相关性脑病临床治疗进展及新策略

Advances and novel strategies in treatment of sepsis-associated encephalopathy

  • 摘要: 约50%的脓毒症患者罹患脓毒症相关性脑病(SAE),严重影响患者预后,目前尚缺乏特异性治疗手段。临床干预 策略以控制原发病和支持治疗为主,结合镇静镇痛药物减少相关风险因素,例如改善谵妄、减轻疼痛、促进脱机拔管、早 期活动等。同时,各种与治疗相关的实验研究不断涌现,主要涉及抑制神经炎症损伤、保护血脑屏障、改善神经细胞能量 代谢减少凋亡、促进修复等方向。其中传统中医中药在SAE的实验研究中显示出积极疗效,值得关注。随着研究的不断深 入,未来SAE临床救治效果有望得以提高。

     

    Abstract: About 50% septic patients develop sepsis-associated encephalopathy (SAE), which might lead to a worse severe prognosis. Until now, effective treatments are not available for this complication. The major treatment is based on the management of protopathy, combined with the handling of relevant complications or medical practices, such as delirium, pain, mechanical ventilation weaning, and early movement. Recently, many experiments focusing on the therapeutic pharmacy are performed to target neuroinflammation, protection of blood brain barrier, cellular energy metabolism, necrosis, and neural restoration. Notably, traditional Chinese medicine shows therapeutic effects in SAE trials. As rapid advancement in new medical techniques, the clinical treatment for SAE is expected to be improved in the future.

     

/

返回文章
返回